RecruitingColorectal PolypColorectal NeoplasmsColorectal Adenoma
Colonoscopy vs Stool Testing for Older Adults With Colon Polyps
Eligible age
65–82 yrs
Accepts
All genders
Locations
16 states
Healthy volunteers
No
See if you qualify for this study
Answer a few quick questions about your location and health. Takes about a minute.
About this study
This is a multi-site comparative effectiveness randomized controlled trial (RCT) comparing annual fecal immunochemical testing (FIT) and colonoscopy for post-polypectomy surveillance among adults aged 65-82 with a history of colorectal polyps who are due for surveillance colonoscopy.
Sponsor: Dartmouth-Hitchcock Medical Center
You may qualify if…
- ✓ English or Spanish speaking
- ✓ Personal history of colorectal polyps
- ✓ Most recent colonoscopy with ≤2 non-advanced polyps
- ✓ Currently due or coming due within 12 months for colonoscopy
- ✓ Able to provide written informed consent
You may not qualify if…
- ✕ Personal history of colorectal cancer
- ✕ Personal history of genetic syndrome with high risk for colorectal cancer (e.g. Lynch Syndrome, Familial Adenomatous Polyposis Syndrome (FAP), or Serrated Polyposis Syndrome)
- ✕ Personal history of inflammatory bowel disease (e.g. ulcerative colitis, Crohn's disease)
- ✕ Most recent colonoscopy with advanced polyp(s) or ≥3 non-advanced polyps
- ✕ Patients unlikely to benefit from polyp surveillance (e.g., history of heart disease or coronary artery disease with treatment in the last 6 months, heart failure affecting function, lung disease requiring use of home oxygen, stroke within the last 4 months, dementia affecting activities of daily living (ADL) or instrumental activities of daily living (IADL), severe liver disease requiring the use of certain medications to control fluid, confusion, or bleeding, severe kidney disease requiring dialysis, or a new cancer diagnosis within the last year)
- ✕ Patients unable to provide written informed consent
Where it's recruiting
Alabama
Birmingham
Arizona
Tucson
California
San Diego · Walnut Creek
Colorado
Aurora
District of Columbia
Washington D.C.
Florida
Tampa
Illinois
Chicago
Indiana
Indianapolis
Michigan
Ann Arbor · Detroit
Missouri
St Louis
New Hampshire
Lebanon
New York
New York
Source: ClinicalTrials.gov · NCT05612347 · last updated 2026-10-02